SEC Form 4 · accession 0001607062-18-000435

Enveric Biosciences, Inc. · ENVB

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

10% Owner

Period of report

Nov 16, 2018

Accepted (ET)

Nov 20, 2018 · 1:44 pm EST

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0000890821

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I	Nature of ownership
Common Stock^F1	Nov 16, 2018	S	58	$0.3028	D	2,349,942	D
Common Stock^F1	Nov 16, 2018	S	1,500	$0.3011	D	2,348,442	D
Common Stock^F1	Nov 16, 2018	S	1,515	$0.3006	D	2,346,927	D
Common Stock^F1	Nov 16, 2018	S	14,119	$0.3003	D	2,332,808	D
Common Stock^F1	Nov 16, 2018	S	15,251	$0.30	D	2,317,557	D
Common Stock^F1	Nov 16, 2018	S	200	$0.2951	D	2,317,357	D
Common Stock^F1	Nov 16, 2018	S	6,657	$0.295	D	2,310,700	D
Common Stock^F1	Nov 16, 2018	S	1,850	$0.294	D	2,308,850	D
Common Stock^F1	Nov 16, 2018	S	58,850	$0.293	D	2,250,000	D
Common Stock^F2	holding	—	—		—	1,650,000	I	Footnote

No Table II lines on this filing.

F1The Lokesh Sikaria Trust Dated 12/14/2012 realized a short-swing profit of $719.35, which it will promptly forfeit to AMERI Holdings, Inc.
F2Determined in accordance with Rule 13d-3(d)(1), as a result of their cooperation and acting in concert, The Lokesh Sikaria Trust Dated 12/14/2012 and The Sikaria Family 2008 Revocable Trust Dated 02/28/2008 are deemed to beneficially own, as a group, 3,900,000 shares of the Issuer's common stock. Chanda Sikaria is one of three trustees of The Lokesh Sikaria Trust Dated 12/14/2012, and the trustees can only act by majority vote to vote or sell the shares beneficially owned by The Lokesh Sikaria Trust Dated 12/14/2012. The Lokesh Sikaria Trust Dated 12/14/2012 expressly disclaims beneficial ownership in the shares beneficially owned by The Sikaria Family 2008 Revocable Trust Dated 02/28/2008